top of page
Dr. Cathy Eng on the BackTable Tumor Board Podcast

Dr. Cathy Eng

Medical Oncologist

1 Podcast on BackTable

Dr. Cathy Eng is a medical oncologist and the David H. Johnson Chair in Surgical and Medical Oncology at Vanderbilt University in Nashville, Tennessee.

Learn from the experiences and expertise of Dr. Cathy Eng and other leading voices in your specialty on the BackTable app.

Applying CheckMate 8HW: Practical Updates for MSI-High CRC
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 75  •  04 Aug 2026

Applying CheckMate 8HW: Practical Updates for MSI-High CRC

Is it time to rethink the definition of “cure” for stage IV colorectal cancer? In this episode of BackTable Tumor Board, medical oncologist Jun Gong interviews Dr. Cathy Eng about updates from the phase III CheckMate-8HW trial in centrally confirmed MSI-high/dMMR metastatic colorectal cancer, comparing nivolumab/ipilimumab, nivolumab, and chemotherapy. They discuss initial findings demonstrating improved progression-free survival and response rates with combination immunotherapy, as well as safety considerations and how comorbidities and frailty guide the choice between single-agent and combination regimens.

This podcast is supported by

Bristol Myers Squibb

More from Dr. Cathy Eng

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page